[144] Amphastar Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

On 06/30/2025, Quest Resource Holding Corp. (QRHC) director Sarah Tomolonius reported the acquisition of 1,732 deferred stock units (DSUs) at an indicated price of $2.02 per unit, under the company’s 2024 Incentive Compensation Plan. These DSUs will convert into common shares when the director separates from the company.

After the transaction, Tomolonius beneficially owns 28,196 DSUs—18,027 granted in 2012 and 10,169 granted in 2024—plus 13,926 common shares held outright. Her total economic exposure therefore rises to approximately 42,122 shares. Ownership remains direct and no derivative securities were involved.

The purchase modestly increases insider alignment but is not material relative to QRHC’s overall share count or trading volume. No indication of a Rule 10b5-1 trading plan was disclosed, and no additional executive or strategic information accompanied the filing.

Positive

• Director increased personal stake by 1,732 DSUs, reinforcing alignment with shareholders.
• Total beneficial ownership rises to ~42,000 shares, indicating continued long-term commitment.

Negative

• Immaterial transaction size relative to QRHC’s float limits market impact.
• DSUs convert only upon separation, so there is no immediate open-market purchase signal.

Insights

Financial Analyst

TL;DR: Small insider buy; signals confidence but negligible impact on valuation.

The 1,732-unit DSU grant lifts the director’s stake by roughly 4% to 42k shares, worth under $90k at recent prices. While continued accumulation aligns incentives and can be viewed positively, the size is immaterial versus QRHC’s float and will not affect liquidity, earnings, or governance metrics. No cash outlay or option exercise occurred, so market signalling power is limited. Overall, the filing is informational, with neutral investment impact.

Corporate Governance Expert

TL;DR: Routine equity grant enhances alignment; governance stance unchanged.

The DSUs vest only upon separation, encouraging long-term stewardship. Such grants are typical for non-employee directors and comply with the 2024 Incentive Plan. Because there are no derivatives, pledges, or sales, the action poses no governance red flags. However, its scale is too small to alter board independence or concentration metrics. I therefore classify the disclosure as routine and not impactful to shareholders.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	500	11715.00	47139085	07/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2022	RSU	Issuer			500	06/07/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Floyd Peterson c/o 11570 SIXTH STREET Rancho Cucamonga CA 91730	Common	03/06/2025	1000	27986.30
Floyd Peterson c/o 11570 SIXTH STREET, Rancho Cucamonga CA 91730	Common	04/01/2025	500	14190.30
Floyd Peterson c/o 11570 SIXTH STREET Rancho Cucamonga CA 91730	Common	05/01/2025	500	12041.45
Floyd Peterson c/o 11570 SIXTH STREET, Rancho Cucamonga CA 91730	Common	06/02/2025	500	12835.05

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many QRHC shares did Director Sarah Tomolonius acquire on June 30, 2025?

She acquired 1,732 deferred stock units under the 2024 Incentive Compensation Plan.

What is Director Tomolonius’s total ownership in QRHC after the transaction?

She now beneficially owns 28,196 DSUs and 13,926 common shares, totaling about 42,122 shares.

At what price were the QRHC deferred stock units valued?

The Form 4 lists a reference price of $2.02 per unit for the DSU grant.

When will the DSUs convert into QRHC common stock?

All DSUs convert to common shares upon the director’s separation from service with the company.

Did the Form 4 report any derivative securities transactions?

No. No derivative securities were acquired or disposed of in this filing.